John David Harling

This inventor holds 21 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property Development Limited, Glaxo Group Limited. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John David Harling. Retrieved from https://idiyas.com/inventor/john-david-harling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 8)

% Patents Active = 42.9

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 122(Granted Patents)

Location History:

Essex, GB (1998)
Sawbridgeworth, GB (2000 - 2004)
Harlow, GB (1998 - 2007)
Stevenage, GB (2007 - 2020)

Company Filing History:

14 out of 2,198

Smithkline Beecham Corporation

patents

6 out of 242

Glaxosmithkline Intellectual Property Development Limited

University of Cambridge

where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10781205 - Conjugates comprising RIPK2 inhibitors (2020-09-22),

2. 10730862 - Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase (2020-08-04),

3. 10435391 - Compounds (2019-10-08),

4. 10336744 - 1AP E3 ligase directed proteolysis targeting chimeric molecules (2019-07-02),

5. 9993514 - Compounds (2018-06-12),

6. 9988376 - Benzothiophene derivatives as estrogen receptor inhibitors (2018-06-05),

7. 7235544 - 3-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors of factor Xa (2007-06-26),

8. 7199239 - Chemical compounds (2007-04-03),

9. 7105536 - Compounds (2006-09-12),

10. 6906089 - Triarylimidazole derivatives as cytokine inhibitors (2005-06-14),

11. 6770657 - Compounds (2004-08-03),

12. 6762192 - Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity (2004-07-13),

13. 6492388 - Substituted isoquinoline derivatives and their use as inticonvulsants (2002-12-10),

14. 6492378 - Substituted isoquinoline derivatives and their use as anticonvulsivants (2002-12-10),

15. 6410555 - Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity (2002-06-25),

Title: John David Harling - The Innovative Mind from Stevenage

Introduction: John David Harling is a renowned inventor hailing from Stevenage, Great Britain, known for his groundbreaking contributions to various industries.

Latest Patents: John David Harling holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, John David Harling has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: John David Harling has collaborated with top universities and multinational corporations to bring his inventions to life, demonstrating his ability to work across different sectors and disciplines.

Conclusion: John David Harling's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.